Stock AnalizBrightSpring Health Services, Inc. BTSG
Medical/Nursing Services · IPO 2024 · data as of November 13, 2026
BrightSpring Health Services, Inc. (BTSG) is a healthcare company listed in the US with a market value of about $14.2B. In the twelve months to September 30, 2026 it had revenue of $15.3B and net income of $410M, a net margin of 2.7%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: a P/E of 50.5, a price to free cash flow of 28.8, a 5-year average ROIC of 7%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 10% below the current price.
Score: 1.2 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- Positive free cash flow
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 4 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $15.3B | $12.9B | $10.1B | $7.7B | $7.7B |
| Net income | $410M | $191M | -$18M | -$155M | -$54M |
| Free cash flow | $492M | $395M | -$57M | $137M | -$75M |
| EPS (diluted) | $1.85 | $0.87 | $-0.09 | $-1.31 | $-0.46 |
| Net margin | 2.7% | 1.5% | -0.2% | -2.0% | -0.7% |
| ROIC | — | 4.9% | 1.7% | 1.2% | 19.7% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 17 analysts is $83.21, 17% above the current price; targets range from $73.50 to $92.00; the consensus rating is “Strong buy”; expected EPS is $1.92 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is BrightSpring Health Services’s P/E ratio?
About 50.5, based on the last twelve months of diluted earnings per share (forward P/E about 31.2).
Is BrightSpring Health Services stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 10% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does BrightSpring Health Services pay a dividend?
Not currently.
Is BrightSpring Health Services a good stock to buy?
We do not give buy or sell advice. BrightSpring Health Services scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.